- Safety and efficacy of recombinant human alpha-galactosidase a replacement therapy in Fabry's disease
- The New England journal of medicine
- Pages (from-to)
- Document type
- Faculty of Medicine (AMC-UvA)
- go to publisher's site
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.